Chapters:
0:00 Welcome and Speaker Introductions
3:09 ATTR Treatment Chart
3:30 Dr. Tony Urey, Current FDA Approved Treatments for ATTR Amyloidosis
21:31 Dr. Chafic Karam, hATTR Polyneuropathy Treatments
42:15 Dr. Tony Urey, Drugs in Clinical Trials (silencers)
59:00 Q&A with Drs. Urey, Karam
1:17:46 Paula Schmitt, Financial Assistance Update
1:26:11 Dr. Tony Urey, Investigational and Anti-fibril Therapies
1:38:17 Q&A 2 with Drs. Urey, Karam
1:44:47 Dr. Jon Wall, Diagnosing Cardiac Amyloid using 99mTc-p5+14 SPECT/CT Imaging
1:59:50 Muriel Finkel & Dr. Urey on BridgeBio ACT-Early trial, use of Tafamidis in BridgeBio ATTRibute-CM study
2:01:44 Muriel Finkel questioning whether pacemakers exclude participants from enrolling in ATTR trials (answer: they usually don't)
This webinar video has been edited for content and time.